Together we will find a cure Donate
Together we will find a cure Donate

News

National brain tumour research funding needs to increase to £35 million a year

Your Choice Cover announces charity partnership

Swansea-based insurance company Your Choice Cover has announced a two-year charity partnership with Brain Tumour Research. 

The business, which helps customers protect their lives, homes and income, hopes to raise as much as £20,000 over the next two years to help find a cure. 

Its support is inspired by one of its employees who knows first hand how devastating a brain tumour diagnosis can be. James Drew, Social Media and Marketing Executive at Your Choice Cover, is engaged to the daughter of brain tumour patient Mark Poulton.  

James said: “It’s shocking to learn that one in three of us know someone affected. Mark’s life has changed dramatically since his diagnosis and I’m delighted that, together with my work colleagues, we will be doing something to help him.” 

Mark will be on chemotherapy for the rest of his life after being diagnosed with a high-grade oligodendroglioma in June 2014. He has since undergone gruelling treatment including 37 rounds of radiotherapy, eight hours of debulking surgery and chemotherapy. 

He said: “It’s great that Your Choice Cover has chosen to support Brain Tumour Research and I’m proud of James for making this happen. This is a great opportunity to bring much needed awareness that the disease so desperately needs.” 

Keith Jones, Director of Your Choice Cover, said: “Our ethos is to put the individual at the centre of everything we do and our motto is ‘in a world where you can be anything, be kind’. This partnership is a great fit and we hope people will be kind and generous in supporting us and this great cause.” 

To support Your Choice Cover’s fundraising, please donate via the organisation’s JustGiving page. 

Related reading:

 If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.